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ABSTRACT
Effects of Acute and Repeated Administration of Diazepam on
Delay Discounting in Lewis and Fischer 344 Rats
Sally L. Huskinson
Impulsive choice is often examined using a delay-discounting procedure where choice is
between two reinforcers of different magnitudes presented at varying delays. Individual
discounting rates can be influenced by many factors including strain differences and drug
effects. Lewis (LEW) and Fischer 344 (F344) rats have behavioral and neurochemical
differences relevant to delay discounting and were used to examine effects of acute and repeated
diazepam administration on impulsive choice. Consistent with previous literature, largerreinforcer choice decreased as a function of increasing delays for all rats, and steeper discounting
functions occurred for LEW relative to F344 rats. Acute and repeated diazepam administration
resulted in differential effects between rat strains and sometimes between subjects within the
same rat strain. Overall, larger-reinforcer choice was unchanged across multiple phases of the
experiment for LEW rats, with some exceptions during the acute phase. For F344 rats, largerreinforcer choice increased following acute administration of smaller doses of diazepam and
decreased following acute administration of the largest dose tested. Decreases in largerreinforcer choice occurred for F344 rats during repeated conditions and persisted throughout a
non-drug baseline phase. Results from the present study have raised more questions about, and
potential directions for future investigation of, multiple environmental, genetic, and
neurochemical variables involved in delay discounting and effects of benzodiazepines on delay
discounting.

iii
Acknowledgements
I would like to thank Karen Anderson, Andy Lattal, and Hawley Montgomery-Downs for
serving as members of my thesis committee and for their valuable input and comments in
preparing this manuscript. I am especially thankful to Karen for serving as the chair of my
committee and as my advisor.

iv
Table of Contents
Abstract ................................................................................................................................................ ii
Acknowledgements ............................................................................................................................. iii
Table of Contents ................................................................................................................................. iv
List of Figures ....................................................................................................................................... v
List of Tables ....................................................................................................................................... vi
Introduction ........................................................................................................................................... 1
Method .................................................................................................................................................. 9
Subjects ........................................................................................................................... 9
Apparatus ...................................................................................................................... 10
Procedure ................................................................................................................. 10
Drugs ........................................................................................................................ 15
Data Analysis ............................................................................................................ 16
Results .................................................................................................................................................. 17
Baseline .................................................................................................................... 17
Determination of the Acute Dose-Response Function................................................... 21
Repeated (Chronic) Drug Administration….................................................................. 28
Determination of the Chronic Dose-Response Function............................................... 31
Baseline Replication………………………………………................................................. 35
Discussion ........................................................................................................................................... 37
References ..................................................................................................................................... 45

v
List of Figures
Figure 1. Mean percent larger-reinforcer choice as a function of delay blocks for the last five baseline sessions (circles) and
for 0-sec probe sessions (squares) conducted during the terminal (baseline) delay series for LEW (closed symbols) and F344
(open symbols) rats. Error bars represent standard error of the mean. The x-axis is composed of blocks rather than delay
values as two LEW and three F344 rats responded in a 0, 5, 10, 20, and 40-s delay series, and six LEW and five F344 rats
responded in a 0, 2, 4, 8, and 16-s delay series. During 0-s probe sessions the delay to the larger reinforcer was 0 s across all
five blocks of trials………………………………………………………………………………………….………………… 19
Figure 2. Mean indifference points (left panel) and AUC (right panel) from the last five sessions of the terminal (baseline)
delay series for LEW (filled bars) and F344 (open bars) rats. Error bars represent standard error of the mean. Single and
double asterisks represent strain differences at p < .05 and p < .01, respectively……………………………………...…….. 20
Figure 3. Mean percent larger-reinforcer choice as a function of delay for acute diazepam administration, including vehicle
(closed squares), 1.0 (open circles), 3.0 (open triangles), and 10.0 (gray diamonds) mg/kg of diazepam for LEW (left panel)
and F344 (right panel) rats. Error bars represent standard error of the mean. The x-axis is composed of blocks rather than
delay values as two LEW and three F344 rats responded in a 0, 5, 10, 20, and 40-s delay series, and six LEW and four F344
rats responded in a 0, 2, 4, 8, and 16-s delay series…………………………………………………...……………………… 26
Figure 4. Mean indifference points (top panel) and AUC (bottom panel) as a function of doses of diazepam (control, vehicle,
1.0, 3.0, and 10.0 mg/kg) during acute drug administration for LEW (closed symbols) and F344 (open symbols) rats. Error
bars represent standard error of the mean. Single and double asterisks represent significance levels of p < .05 and p < .01,
respectively, where differences occurred between rat strains at a particular dose. Single and double crosses represent
significance levels of p < .05 and p < .01, respectively, where significant changes for a particular dose occurred relative to
vehicle for each strain separately………………………………………………………………………...…………………. 27
Figure 5. Mean percent larger-reinforcer choice as a function of delay during acute vehicle administration (closed squares)
and the first (open triangles) and last (gray triangles) five sessions of repeated diazepam administration. Error bars represent
standard error of the mean. The x-axis is composed of blocks as one LEW and three F344 rats responded in a 0, 5, 10, 20,
and 40-s delay series, and six LEW and three F344 rats responded in a 0, 2, 4, 8, and 16-s delay
series………………………………………………………………………………………………...………………………… 30
Figure 6. Mean percent larger-reinforcer choice as a function of delay during determination of the chronic dose-response
function, including vehicle (closed squares), 1.0 (open circles), 3.0 (open triangles), and 10.0 (gray diamonds) mg/kg of
diazepam for LEW (left panel) and F344 (right panel) rats. Error bars represent standard error of the mean. The x-axis is
composed of blocks rather than delay values as one LEW and three F344 rats responded in a 0, 5, 10, 20, and 40-s delay
series, and six LEW and three F344 rats responded in a 0, 2, 4, 8, and 16-s delay series……………………………………. 33
Figure 7. Mean indifference points (top panels) and AUC (bottom panels) as a function of doses of diazepam (vehicle, 1.0,
3.0, and 10.0 mg/kg) during acute (closed symbols) and chronic (open symbols) drug administration for LEW (left panels)
and F344 (right panels) rats. Error bars represent standard error of the mean. Single and double asterisks represent
significance levels of p < .05 and p < .01, respectively, where differences occurred between acute and chronic administration
at a particular dose……………………………………………………………………………………………………………. 34
Figure 8. Mean percent larger-reinforcer choice as a function of delay blocks for the last five sessions conducted during the
terminal (baseline) delay series (circles) and last five sessions from the baseline replication phase (squares) for only those
LEW (left panel) and F344 (right panel) rats that completed all phases of the experiment. Error bars represent standard error
of the mean. The x-axis is composed of blocks rather than delay values as one LEW and three F344 rats responded in a 0, 5,
10, 20, and 40-s delay series, and six LEW and three F344 rats responded in a 0, 2, 4, 8, and 16-s delay series……………. 36

vi
List of Tables

Table 1. Subject, terminal delay series (Delay Series), number of 0-s probe sessions conducted
during the terminal delay series (0-s probes Baseline), number of sessions during the terminal
delay series (Baseline), number of 0-s probe sessions conducted during the acute phase (0-s
probes Acute), number of sessions during determination of the acute dose-response function
(Acute DEC), the chronic dose selected for individual subjects (Chronic Dose), number of
sessions during repeated diazepam administration for 30-50 sessions (Repeated), number of
sessions during determination of the chronic dose-response function (Chronic DEC), number of
0-s probe sessions conduction after completion of chronic diazepam administration (0-s probes),
and number of sessions conducted during the baseline replication at the end of experimentation
(Baseline 2). Means and standard error of the means (SEM) are shown for each strain
separately……………………………………………………………………………………… 18
Table 2. Subject, terminal delay series (Delay Series), and indifference points for each subject
during the terminal delay series (Baseline), determination of the acute dose-response function
(Control, VEH, 1.0, 3.0, and 10.0 mg/kg), first five (First 5 Repeated) and last five (Last 5
Repeated) sessions of repeated administration of diazepam for 30-50 sessions, determination of
the chronic dose-response function (VEH, 1.0, 3.0, and 10.0 mg/kg), and baseline replication at
the end of experimentation (Baseline 2)………………………………………………………... 24
Table 3. Subject, terminal delay series (Delay Series), and AUC for each subject during the
terminal delay series (Baseline), determination of the acute dose-response function (Control,
VEH, 1.0, 3.0, and 10.0 mg/kg), first five (First 5 Repeated) and last five (Last 5 Repeated)
sessions of repeated administration of diazepam for 30-50 sessions, determination of the chronic
dose-response function (VEH, 1.0, 3.0, and 10.0 mg/kg), and baseline replication at the end of
experimentation (Baseline 2)…………………………………………………………………… 25

1
Introduction
Behavior identified as impulsive is associated with psychological and behavioral
disorders such as attention-deficit/hyperactivity disorder (ADHD), gambling, substance abuse,
eating disorders, and others (Evenden, 1999; Evenden & Ryan, 1996; Kollins, 2003; Perry &
Carroll, 2008; Reynolds, 2006). A greater understanding of neurological, genetic, and
behavioral mechanisms that underlie impulsive behavior may enhance the understanding and
treatment of problem disorders. Impulsive behavior is correlated with substance abuse, though it
is unclear whether high rates of impulsive behavior leads to substance abuse, substance abuse
leads to high rates of impulsive behavior, or if both impulsive behavior and substance abuse are
related through an unknown third variable. In the laboratory, a delay-discounting procedure is
often used to assess impulsive choice in both human and animal models (e.g., Ainslie, 1975;
Bickel, Odum, & Madden, 1999; Mazur, 1987).
Delay-Discounting Procedure
Using the delay-discounting procedure, impulsive choice is examined by providing
subjects with a choice between two reinforcers of different magnitudes presented at varying
delays (Ainslie, 1975; Anderson & Woolverton, 2005; Mazur, 1987). Impulsive choice in this
context is operationally defined as choosing a smaller, more immediate reinforcer over a larger,
more delayed reinforcer, and an indifference point, or the delay value at which the smaller and
larger reinforcer are chosen equally, can be interpolated. The effectiveness of the larger delayed
reinforcer is said to be devalued, or discounted, as a function of delay, and its subjective value
may become less than the smaller immediate reinforcer. Shorter indifference points or steeper
discounting curves indicate higher rates of impulsive choice.
Many argue that delay discounting is best described by the hyperbolic equation: V = A/(1
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+ kD), where V represents reinforcer value, A represents reinforcer amount, D represents
reinforcer delay, and k is a free parameter used to indicate the rate of decrease in value, or rate of
discounting (e.g., Mazur, 1987; Myerson & Green, 1995; Perry & Carroll, 2008). This equation
predicts that the value of a reinforcer decreases faster at shorter delays and more slowly at longer
delays as a function of delay to its presentation, and higher k values indicate steeper discounting
rates. Many studies, some of which are described below, have utilized this hyperbolic model for
various comparisons of discounting rates between different subjects, different magnitudes of
reinforcers, or qualitatively different reinforcers with both human and non-human animals.
Drug Exposure and Delay Discounting
Numerous studies find steeper delay-discounting functions, which indicate a more rapid
devaluation of the larger reinforcer as a function of delay, in substance users compared to
nonusers (see Reynolds, 2006 for a review). For example, Kollins (2003) examined choice
between an adjusting amount of hypothetical money delivered immediately versus a larger
amount delivered after a delay. Steeper discounting curves were associated with self-report
measures of younger first use of cigarettes, alcohol, and marijuana, higher rates of “passing out”
from alcohol use, and higher number of lifetime illicit drug use. Other studies targeting more
specific drug classes indicate that alcohol (Petry, 2001), nicotine (Bickel et al., 1999; Mitchell,
1999; Reynolds, Richards, Horn, & Karraker, 2004), opiate (Madden, Petry, Badger, & Bickel,
1997; Madden, Bickel, & Jacobs, 1999), cocaine (Coffey, Gudleski, Saladin, & Brady, 2003),
and methamphetamine abusers (Hoffman et al. 2006; Monterosso et al. 2007) discount delayed
reinforcers more steeply than non-users, or ex-users (see Reynolds, 2006 for a review). Drugdependent participants also discounted hypothetical cigarettes (Bickel et al., 1999), heroin
(Madden et al., 1997; Madden et al., 1999), and cocaine (Coffey et al., 2003) at a significantly
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higher rate than hypothetical money.
Laboratory research with non-human animals indicates a relation between drug selfadministration and delay discounting. Rats categorized as high on impulsive choice
subsequently self-administered more freely available, orally delivered ethanol (Poulos, Le, &
Parker, 1995), more quickly acquired intravenous cocaine self-administration, and over the last
five sessions of acquisition, self-administered more cocaine compared to rats categorized as low
impulsive (Perry, Larson, German, Madden, & Carroll, 2005; Perry, Nelson, & Carroll, 2008).
Additionally, rats categorized as high impulsive lever pressed more for nicotine infusions at
fixed-ratio (FR) values of 20 and 25 compared to those categorized as low impulsive (Diergaarde
et al., 2008). These results suggest that higher rates of impulsive choice may precede substance
abuse. Other laboratory research has shown that exposure to a drug, via experimenter
administration, may affect performance on subsequent delay-discounting tasks. Simon, Mendez,
and Setlow (2007) examined two groups of rats exposed to either a high dose of cocaine (30
mg/kg) or saline for 14 days followed by three weeks with no testing or dosing. The group of
rats exposed to cocaine chose the larger-reinforcer less often than the group exposed to saline.
This suggests that exposure to a commonly abused drug like cocaine may somehow alter
impulsive choice.
Behavioral Differences Between Lewis and Fischer 344 rats
Researchers have examined roles of behavioral and genetic factors on impulsive choice
and their relation to substance use by comparing different rat strains. Comparisons between
Lewis (LEW) and Fischer 344 (F344) rats provide evidence of behavioral differences that may
be relevant to delay discounting and substance abuse. Using a delay-to-reinforcement procedure
for acquisition of lever pressing, Anderson and Elcoro (2007) found that more LEW than F344
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rats acquired the response. Compared to F344 rats, LEW rats consume more freely available
food adulterated with morphine and codeine than standard unadulterated rat chow (Suzuki,
Otani, Koike, & Misawa, 1988) and have higher progressive-ratio breakpoints for intravenous
administration of morphine across various doses (Garcia-Lecumberri et al., 2010). LEW rats
more readily acquire a lever press maintained by intravenous cocaine administration and initially
self-administer larger amounts of cocaine than F344 rats (Freeman, Kearns, Kohut, & Riley,
2009; Kosten et al., 1997). Once self-administration of cocaine is established, however, LEW
rats self-administer less, have lower progressive-ratio breakpoints, and more elastic demand
curves (Christensen, Kohut, Handler, Silberberg, & Riley, 2009; Freeman et al. 2009; Kosten,
Zhang, & Haile, 2007). When ethanol was a consequence for lever pressing, LEW rats had
higher response rates and oral intake of ethanol under various FR schedules than F344 rats
(Suzuki, George, & Meisch, 1988).
LEW rats also have shorter indifference points compared to F344 rats when utilizing a
within-session adjusting-delay procedure where delay to the larger reinforcer systematically
increased within single sessions (Anderson & Diller, 2010; Anderson & Woolverton, 2005;
Garcia-Lecumberri et al., 2010; Huskinson, Krebs, & Anderson, revisions submitted). This
finding was replicated by systematically increasing delays between sessions (Madden, Smith,
Brewer, Pinkston, & Johnson, 2008). Using an adjusting-amount procedure, however, LEW and
F344 rats did not differ in baseline levels of impulsive choice (Wilhelm & Mitchell, 2009).
Role of Dopamine and Serotonin in Delay Discounting
LEW and F344 rats have neurochemical differences that may be relevant to delay
discounting. LEW rats have fewer dopamine (DA) receptors (specifically D2 and D3) and DA
transporters in some brain regions than F344 rats (Flores, Wood, Barbeau, Quiron, & Srivastava,
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1998), and LEW rats have lower levels of serotonin (5-HT) and fewer 5-HT1A receptors in some
brain regions compared to F344 rats (Burnet, Mefford, Smith, Gold, & Sternberg, 1992; Selim &
Bradberry, 1996). Previous research examining neurochemical factors that affect impulsive
choice suggest that these systems play important roles in impulsive behaviors (see Cardinal,
Robbins, & Everitt, 2003 for a review). Depletion of DA in rats by injection of 6hydroxydopamine (6-OHDA) into the orbital prefrontal cortex (Kheramin et al., 2004) and
depletion of 5-HT by injection of the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) in the
dorsal and median raphe nuclei (Mobini et al., 2000; Wogar, Bradshaw, & Szabadi, 1993)
increased choice of a smaller, immediate reinforcer at shorter delays compared to rats that
received sham lesions. Delay discounting was not affected by global 5-HT depletion when
intracerebroventricular infusions of 5,7-DHT or vehicle were administered to rats matched
according to baseline performance (Winstanley, Dalley, Theobald, & Robbins, 2003). Global 5HT depletion did, however, inhibit the ability of d-amphetamine, an indirect DA agonist, to
increase larger-reinforcer choice in the lesioned compared to non-lesioned animals (Winstanley
et al., 2003).
To further support the role of DA and 5-HT in impulsive choice, there are indications that
acute administration of DA and 5-HT drugs, particularly psychomotor stimulants such as damphetamine, may affect delay discounting, though results have been mixed. Increases in
larger-reinforcer choice occurred following administration of d-amphetamine (Cardinal,
Robbins, & Everitt, 2000; Huskinson et al., revisions submitted; Wade, de Wit, & Richards,
2000; Winstanley et al., 2003) and dexfenfluramine, a 5-HT releaser (Poulos, Parker, & Le,
1996). However, administration of d-amphetamine and DOI, a 5-HT2 agonist, also decreased
larger-reinforcer choice (Cardinal et al., 2000; Evenden & Ryan, 1996; 1999; Slezak &
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Anderson, 2009). DA antagonists, flupenthixol and raclopride, decreased larger-reinforcer
choice (Cardinal et al.; Wade et al., 2000), and SCH 23390, also a DA antagonist, had no effect
(Wade et al.). It is possible that different baseline rates of delay discounting (Perry, Stairs, &
Bardo, 2008) and presence or absence of a cue during the delay (Cardinal et al.) may account for
these discrepancies. The interaction between DA and 5-HT drugs and delay discounting requires
additional research.
CNS Depressants: Effects on Dopamine and Serotonin
Compared to psychomotor stimulants, such as d-amphetamine, there is much less
research regarding what effects administration of central nervous system (CNS) depressants such
as ethanol and benzodiazepines would have on impulsive choice. Both ethanol and
benzodiazepines have facilitative actions on the CNS inhibitory neurotransmitter system gammaAminobutyric acid (GABA), with specific action at the GABAA receptor site (e.g., Lobo &
Harris, 2008), in addition to actions on DA and 5-HT systems. Acute administration of ethanol
increased extracellular levels of DA and 5-HT in the nucleus accumbens of Wistar rats
(Yoshimoto, McBride, Lumeng, & Li, 1992) and increased extracellular DA in the nucleus
accumbens in F344 but not LEW rats (Mocsary & Bradberry, 1996). The 5-HT agonist parachloroamphetamine can reduce impulsive behavior induced by ethanol (Olmstead, Hellemans, &
Paine, 2006), and ethanol self-administration increased levels of extracellular DA in Long-Evans
and Wistar rats (Doyon, Anders, Ramachandra, Czachowski, & Gonzales, 2005; Weiss, Lorang,
Bloom, & Koob, 1993).
Benzodiazepines decreased 5-HT neuronal activity and release in specific brain regions
(Stein, Wise, & Belluzzi, 1975). Administration of diazepam, a benzodiazepine, decreased basal
levels of extracellular DA in the prefrontal cortex of rats (Finlay, Zigmond, & Abercrombie,
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1995) and attenuated extracellular levels of DA and 3,4-dihydroxyphenylacetic acid (a DA
metabolite) that were increased in the prefrontal cortex of rats via acute tail pressure and foot
shock, respectively (Finlay et al., 1995; Roth, Tam, Ida, Yang & Deutch, 1988).
Benzodiazepines may also differentially affect LEW and F344 rats. LEW rats developed less
physical dependence and withdrawal compared to F344 rats following repeated exposure and
removal of food mixed with diazepam (Suzuki, Lu, Motegi, Yoshii, & Misawa, 1992).
CNS Depressants and Delay Discounting
Results from acute administration of ethanol and benzodiazepines on delay discounting in
humans are mixed. Using an adjusting-amount task, Richards, Zhang, Mitchell, and de Wit
(1999) found no differences in impulsive choice following oral administration of different doses
of alcohol or placebo. Conversely, Ortner, MacDonald, and Olmstead (2003) found that blood
alcohol level was negatively correlated with discounting slope. Following consumption of 0.7
g/kg of alcohol, a placebo drink, or no drink, participants in the alcohol group had higher
indifference points compared to the non-alcohol groups. These results suggest that acute alcohol
administration increases self-controlled choice in humans. Administration of therapeutically
effective doses of diazepam (5 and 10 mg) and larger doses of diazepam (20 mg) did not affect
rates of delay discounting in humans (Reynolds, Richards, Dassinger, & de Wit, 2004; Acheson,
Reynolds, Richards, & de Wit, 2006).
Effects of acute ethanol and benzodiazepine administration on impulsive choice in rats
are also mixed. Using a T-maze procedure, Olmstead and colleagues (2006) examined effects of
alcohol on choice between two food pellets delivered immediately, and twelve food pellets
delivered after a 10-s delay. Alcohol, at all doses tested (0.6-1.8 g/kg), decreased largerreinforcer choice relative to vehicle administration. Also using a T-maze procedure, Bizot,
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Bihan, Puech, Hamon, and Theibot (1999) found that bretazenil, a partial benzodiazepine
agonist, reduced larger-reinforcer choice at a 15-s delay while alprazolam, a full benzodiazepine
agonist, had no effects at a 15-s delay and increased larger-reinforcer choice at a 25-s delay.
Diazepam and muscimol, a GABA agonist, decreased larger-reinforcer choice at a 15-s delay
and had no effect at a 25-s delay (Bizot et al., 1999). Other researchers employing a T-maze
procedure with rats found that diazepam decreased larger-reinforcer choice at 15 and 30-s delays,
and other benzodiazepines (nitrazepam, chlordiazepoxide, and clobazam) have the same effect at
a 15-s delay (Thiebot, Bihan, Soubrie, & Simon, 1985).
Using a different delay-discounting procedure, where rats chose between a lever that
delivered a smaller reinforcer immediately versus a lever that delivered a larger reinforcer after
varying delays, ethanol decreased larger-reinforcer choice relative to saline (Tomie, Aguado,
Pohorecky, & Benjamin, 1998) and water (Evenden & Ryan, 1999). Administration of
chlordiazepoxide also decreased larger-reinforcer choice depending on dose and presence of a
cue signaling the delay (Cardinal et al., 2000), while diazepam increased larger-reinforcer choice
(Evenden & Ryan, 1996) or had no effect (Charrier & Thiebot, 1996). It is possible that the
various procedures used resulted in the mixed findings across studies.
Statement of the Problem
Previous studies that examined substance abuse and its relation to delay discounting have
included participants with a history of long-term drug exposure. It is possible that the increased
impulsive choice observed in these participants developed as result of repeated exposure to
drugs, although it cannot be ruled out that the participants had higher rates of impulsive choice
prior to drug exposure. Using an animal model, it is possible to detect differences in impulsive
choice during a baseline condition where animals have no previous drug exposure compared to
impulsive choice following acute and repeated, experimenter-administered, drug exposure.
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Although numerous studies have examined effects of stimulant drugs on impulsive
choice, relatively few have examined effects of acute and repeated administration of CNS
depressants, particularly benzodiazepines, and what effects they have on impulsive choice.
Benzodiazepines such as diazepam are widely used as anxiolytics, muscle relaxants,
anticonvulsants, and are often abused at larger doses (Woods, Katz, & Winger, 1987). To date,
no researchers have examined effects of experimenter-administered benzodiazepines on delay
discounting with LEW and F344 rats. Using two rat strains known to differ in baseline rates of
delay discounting and their neurochemical response to CNS depressants may give insight into
behavioral and biological determinants of impulsive choice. The present experiment evaluated
effects of exposure to acute and repeated administration of diazepam on delay discounting in
LEW and F344 rat strains. This study was designed to assess whether LEW and F344 rats differ
in percent larger-reinforcer choices at baseline, and whether acute or repeated administration of
diazepam differentially affects percent larger-reinforcer choice.
Method
Subjects
Eight experimentally naïve male LEW rats and eight experimentally naïve male F344 rats
(Harlan Sprague-Dawley, Inc., Indianapolis, IN) served as subjects. Rats were approximately
three months old at the start of experimentation, and consistent with previous findings, LEW rats
(M=298 g, SEM=4.0) weighed slightly more than F344 rats (M=283 g, SEM=3.6) (e.g.,
Christensen et al., 2009). Overall, this strain difference was observed throughout
experimentation. Rats were housed individually with free access to water in their home cages.
Temperature and humidity were maintained at constant levels, and a reverse 12-hour light-dark
cycle was in place. All sessions were conducted during the dark phase of the light-dark cycle at
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approximately the same time each day. The subjects were fed approximately 10-12 g of food
one half hour following each experimental session. This schedule resulted in about 21 hours of
food restriction prior to the start of each session.
Apparatus
Experimental sessions were conducted in eight standard operant-conditioning chambers
for rats, each enclosed in a melamine sound-attenuating cubicle (Med Associates, VT). Each
chamber contained a working area of 30.5 cm by 24.5 cm by 21.0 cm, a grid floor, and a 45-mg
pellet dispenser with a pellet receptacle that was centered between two retractable response
levers. The levers were 11.5 cm apart from each other and required at least a force 0.25 N for a
response to be recorded. The levers were 4.8 cm wide, protruded 1.9 cm into the chamber, and
were elevated 8 cm from the grid floor. Two 28-V stimulus lights, 2.5 cm in diameter, were 7
cm above each lever. Each chamber contained a 28-V houselight on the wall opposite to the wall
containing the operandum. A ventilation fan circulated air and served to mask extraneous noise.
Equipment was interfaced to a computer, and experimental sessions and data collection were
programmed and conducted with MedPC-IV software (Med Associates, VT).
Procedure
Initial training. During initial lever-press training, food was delivered according to a
conjoint variable-time (VT) 1-min, fixed-ratio (FR) 1 schedule. During these initial training
sessions, both levers were extended into the chamber, and one 45-mg food pellet was delivered
every minute on average and following a press on either lever. Sessions lasted until 60 food
pellets were delivered. If at least 40 of the 60 total food pellet deliveries were not being earned
according to the FR 1 component after four sessions under the conjoint VT 1-min, FR 1
schedule, lever pressing was shaped using reinforcement of successive approximations.
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Following the hand-shaping procedure, lever pressing was reinforced according to an FR 1
schedule with both levers extended, and a press on either lever resulted in delivery of a food
pellet. Once lever pressing was established by either method (free-operant acquisition or hand
shaping), it was reinforced according to an FR 1 schedule where only one lever had a
programmed consequence of food delivery. After five food pellets were earned for presses on a
single lever, an extinction schedule for that lever commenced, and the FR 1 contingency was
alternated to the second lever. This alternating procedure occurred within each session until 40
food pellets were earned. Daily sessions continued until the subjects reliably earned food on
both levers.
General procedure. After training sessions were complete, delay-discounting sessions
began. Sessions began with a 10-min blackout period, during which the chamber was
completely dark before the trials began. Following the blackout period, each session consisted of
five blocks of eight trials each. Trials consisted of forced- and free-choice trials that started
every 100 s. The first two trials in each block were forced-choice trials with one, randomly
determined, lever extended into the chamber, and the cue light directly above it illuminated. A
lever press (FR 1) on the extended lever resulted in the lever being retracted into the chamber,
the cue light darkening, and either a single food pellet was delivered immediately or three food
pellets were delivered after a delay. At the start of the second forced-choice trial, the other lever
was extended into the chamber, the cue light directly above it was illuminated, and the other
outcome was available dependent on a single lever press (FR 1).
After exposure to both outcomes during the forced-choice trials, the remaining six trials
in each block were free-choice trials. During these trials, both cue lights were illuminated, both
levers were extended into the chamber, and the subject was allowed to choose one alternative.
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The lever correlated with the larger reinforcer remained constant within and across sessions. A
press on either lever (FR 1) resulted in both levers being retracted, both cue lights darkening, and
one immediate or three delayed food pellets were delivered, depending on which lever was
pressed. If no lever press occurred within 30 s of a trial onset, the trial was recorded as an
omission, the levers were retracted, and the cue lights darkened.
After completion of the six free-choice trials within a block, the delays to the three-pellet
option were increased across the session in consecutive blocks while the one-pellet option was
always delivered immediately. In the first block of eight trials, the delay to the larger reinforcer
was always 0 s. All sessions started with a delay series of 0 s in all five blocks. When choice of
the larger reinforcer was at least 80% in each block, and for no more than three sessions, the
delays were increased to a series of 0, 1, 2, 4, and 6 s across blocks. The 6-s delay series
remained in effect until the total number of larger-reinforcer choices during the free-choice trials
in the 0-s block was at or above 80%. The delays were then increased to 0, 2, 4, 8, and 16 s
across blocks.
After the 16-s delay series, the delay series was increased or decreased as necessary for
individual subjects to obtain discounting functions with no ceiling or floor effects (i.e., near
exclusive choice for the larger or smaller reinforcer). Only if ceiling effects were obtained
during the 16-s delay series, were the delays increased to 0, 5, 10, 20, and 40 s across blocks, and
if necessary, to 0, 10, 20, 40, and 60 s across blocks. Sessions ended after 40 total (10 forcedand 30 free-choice) trials and were initially conducted five days per week. Six months into the
experiment, sessions were conducted seven days per week. No systematic differences were
observed between those subjects that received five compared to seven sessions per week during
the baseline phase.
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Baseline. Once choice was maintained at a single terminal delay series, a baseline was
established. The terminal (baseline) delay series was in effect for a minimum of 20 sessions plus
the number of sessions until responding was stable. Stability was defined as 80% or greater
choice for the larger reinforcer in the 0-s delay block, less than 20% variation in total largerreinforcer choice during each of the last five sessions from the grand mean, and no increasing or
decreasing trends between the total number of larger-reinforcer choices for each session across
the last five sessions. To ensure sensitivity to the variations in reinforcer magnitude, all delays
during a single session were set equal to zero at least once per week (0-s probe sessions) during
exposure to the terminal delay series (Cardinal et al., 2000; Diller, Saunders, & Anderson, 2008;
Evenden & Ryan, 1996; 1999). Levers associated with the larger-reinforcer delivery were
counterbalanced across subjects such that half of each group had the left lever associated with
the larger reinforcer and half of each group had the right lever associated with the larger
reinforcer.
Determination of the acute dose-response function. After establishing stable baseline
data, acute effects of diazepam administration were assessed. Either vehicle or diazepam (1.0,
3.0, and 10.0 mg/kg) were administered by intraperitoneal injection two times per week,
separated by at least two sessions, as long as two criteria were met. First, at least 80% of lever
presses occurred on the lever associated with the larger reinforcer in each block during sessions
when all delays were set equal to zero. Second, during control sessions, the session immediately
preceding vehicle or drug sessions, at least 80% of lever presses occurred on the lever associated
with the larger reinforcer in the first block when both delays were 0 s. Before the first diazepam
administration, vehicle was administered at least twice. Initially, half of LEW and half of F344
rats received smaller doses of diazepam (0.3, 0.56 and 1.0 mg/kg) in descending order, and the
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other half received them in ascending order. Because these doses did not result in any observed
behavioral effects, it became necessary to increase the doses to those listed above, and all
analyses include only 1.0, 3.0, and 10.0 mg/kg of diazepam. Each of the latter doses of
diazepam were determined at least twice for each subject, and intermediate doses (1.7 and 5.6
mg/kg) were administered when intermediate drug effects needed to be determined. A third or
fourth determination of a particular dose occurred when there was a substantial amount of
variability in larger-reinforcer choice between the first and second determinations.
Repeated (chronic) drug administration. Once acute drug effects were determined, a
dose of diazepam that resulted in the largest change in percent larger-reinforcer choice and
maintained responding at 80% or greater for the larger reinforcer in the first block was
administered repeatedly (chronic dose). If no change in percent larger-reinforcer choice
occurred during acute diazepam administration, the largest dose of diazepam that did not
completely suppress responding was used. To determine effects of repeated exposure to
diazepam, experimental sessions were conducted seven days per week, and the chronic dose was
administered daily prior to the start of each session. Repeated administration occurred for a
minimum of 30 sessions and until choice was stable or a maximum of 50 sessions to ensure
approximately the same amount of repeated drug exposure across subjects. In this condition,
stability was defined as no more than 20% variation in the total number of larger-reinforcer
choices during each of the last five sessions from the grand mean and no increasing or decreasing
trends in the total number of larger-reinforcer choices across the last five sessions. During this
phase, the delays were no longer set equal to zero once per week.
Determination of the chronic dose-response function. Following repeated
administration of the (single) chronic dose of diazepam, the dose-response function was
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redetermined to allow for comparisons of larger-reinforcer choice before and after repeated
diazepam exposure. Two times per week, with at least two sessions in between, the repeated
dose was substituted with one of the previously administered doses of diazepam (1.0, 3.0, & 10.0
mg/kg) and vehicle. Each dose and vehicle administration was determined at least twice for each
subject. A third or fourth determination of a particular dose occurred if there was a substantial
amount of variability in larger-reinforcer choice between the first and second determinations.
Baseline replication. At the end of drug experimentation, diazepam administration
ceased, and subjects that completed the repeated phase were exposed to 0-s probe sessions where
all delays were set equal to 0 s across the five blocks of trials. These sessions were conducted
until larger-reinforcer choice was at least 80% across all blocks for each subject. Once this
criterion was met, conditions were the same as those during the terminal baseline phase.
Sessions were conducted seven days per week, with the terminal delay series in effect, except
once per week (Wednesdays) when 0-s probe sessions were conducted until larger-reinforcer
choice was at least 80% across all blocks of trials. This phase was in effect for a minimum of 20
sessions with the exception of LEW-2 and LEW-8 that received 19 and 15 sessions, respectively,
and until choice was stable. The stability criteria were identical to those used during the terminal
baseline phase. LEW-2 and LEW-8 did not meet the minimum session requirement as a result of
equipment malfunction, however, the choice data from the last five sessions met stability criteria.
Drugs
Diazepam was obtained from Sigma-Aldrich (St. Louis, MO, USA) and was dissolved in
0.9% sodium chloride plus varying concentrations of Tween 80 (2, 3, 5, and 10%). Diazepam
was injected in a volume of 1.0 mg/kg. Vehicle (0.9% sodium chloride plus varying
concentrations of Tween 80) or diazepam (1.0, 3.0 and 10.0 mg/kg) was administered via
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intraperitoneal injections immediately prior to experimental sessions. For the largest dose of
diazepam, three drops of ethanol were added to every 5.0 mls of solution.
Data Analysis
Percent choice for the larger reinforcer was the main dependent measure used. From this
measure, indifference points and area under the curve (AUC) were calculated for each subject in
each condition. Delay-discounting functions for each condition were plotted as percent choice
for the larger reinforcer across increasing delays in each block. Using nonlinear regression, a
function was fit to the data, and indifference points (delay value at which choice for the larger
and smaller reinforcer are equal) were interpolated based on these functions. AUC was derived
by calculating the area of trapezoids that were formed by drawing vertical lines from the
normalized x-axis to each obtained percent choice for the larger reinforcer at each delay. The
areas of these trapezoids were added together and divided by the entire possible area of the graph
(Myerson, Green, & Warusawitharana, 2001). It is important to note that because the x-axis was
normalized when calculating AUC, this measure does not take into account different delay series
used in the present study. By using this measure, all delay series were transformed into a scale
that ranged from zero to one.
To assess strain differences at baseline and following acute and repeated administration
of diazepam on delay discounting, one-way analysis of variance (ANOVA) were conducted. To
assess drug affects within each strain separately, repeated measures ANOVAs were conducted.
Rat strain was a between-subjects variable and indifference points and AUC for acute and
repeated doses of diazepam were within-subjects variables. Planned comparisons were made
between each dose of diazepam and vehicle and between each repeated dose compared to each
acute dose. Independent samples t-tests were conducted to examine differences in the number of
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0-s probe sessions and number of sessions in each condition between LEW and F344 rats.
Results
Baseline
The number of sessions conducted during the terminal baseline condition and number of
0-s probe sessions conducted during baseline for individual subjects are presented in Table 1.
There was no difference between the number of sessions for LEW and F344 rats to reach
stability during the terminal baseline condition. LEW rats did, however, require more 0-s probe
sessions during the terminal baseline condition compared to F344 rats [t(14) = 3.10, p < .01].
Figure 1 shows mean percent larger-reinforcer choice as a function of delay to the larger
reinforcer (displayed as blocks of trials) for LEW (closed symbols) and F344 (open symbols) rats
during the last five sessions of the terminal baseline (circles) and for all 0-s probe sessions
(squares) conducted during the terminal baseline condition. During 0-s probe sessions, mean
larger-reinforcer choice remained above 80% across all blocks of trials for both rat strains.
During sessions when the delay to the larger reinforcer increased, choice for that alternative
decreased for all subjects, and this occurred to a greater extent for LEW compared to F344 rats.
The finding that more impulsive choices occurred for LEW compared to F344 rats is also
indicated in Figure 2 which shows indifference points (left panel) and AUC (right panel) for each
rat strain during the terminal baseline condition (see Tables 2 and 3 for indifference points and
AUC, respectively, for individual subjects). LEW rats had shorter indifference points (M = 6.6 s,
SEM = 0.8 s) and smaller AUCs (M = 0.40, SEM = 0.04) compared to F344 rats (M = 17.3 s,
SEM = 4.4 s; M = 0.61, SEM = 0.04, respectively) [F(1,15) = 5.88, p < .05; F(1,15) = 16.34, p <
.01, respectively].
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Table 1
Subject, terminal delay series (Delay Series), number of 0-s probe sessions conducted during the terminal delay series (0-s probes Baseline),
number of sessions during the terminal delay series (Baseline), number of 0-s probe sessions conducted during the acute phase (0-s probes
Acute), number of sessions during determination of the acute dose-response function (Acute DEC), the chronic dose selected for individual
subjects (Chronic Dose), number of sessions during repeated diazepam administration for 30-50 sessions (Repeated), number of sessions during
determination of the chronic dose-response function (Chronic DEC), number of 0-s probe sessions conduction after completion of chronic
diazepam administration (0-s probes), and number of sessions conducted during the baseline replication at the end of experimentation (Baseline
2). Means and standard error of the means (SEM) are shown for each strain separately
Subject

Delay
Series

0-s probes
Baseline

Baseline

0-s probes
Acute

Acute
DEC

Chronic Dose
(mg/kg)

LEW-1
LEW-2
LEW-3
LEW-4
LEW-5
LEW-6
LEW-7
LEW-8

16
40
16
16
16
16
40
16

15
16
33
4
27
16
15
13

20
53
35
22
34
29
38
44

24
14
30
5
29
36
16
16

82
57
61
30
68
71
57
40

1.7
10.0
10.0
10.0
10.0
5.6
--/-3.0

17.4 (3.1)

34.4 (3.9)

21.3 (3.6)

58.3 (5.9)

9
9
7
5
7
6
10
7

35
29
35
23
27
37
21
27

15
16
21
21
17
6
15
--/--

54
46
68
63
63
73
51
--/--

7.5 (0.6)

29.3 (2.1)

15.9 (1.9)

59.7 (3.7)

LEW
M(SEM)
F344-1
F344-2
F344-3
F344-4
F344-5
F344-6
F344-7
F344-8
F344
M(SEM)

16
16
40
40
16
16
40
16

1.0
1.0
10.0
10.0
10.0
--/-5.6
--/--

Chronic
DEC

0-s
probes

Baseline 2

39
20
22
25
39
46
--/-40

1
1
2
1
3
2
--/-6

22
19
22
21
20
29
--/-15

34.3 (1.6)

33.0 (3.5)

2.3 (0.7)

21.1 (4.2)

30
33
40
35
36
--/-30
--/--

37
41
22
29
44
--/-31
--/--

1
3
3
2
1
--/-2
--/--

20
23
24
24
20
--/-20
--/--

34.0 (1.6)

34.0 (3.3)

2.0 (0.4)

21.8 (0.8)

Repeated
32
43
32
31
32
36
--/-34

Percent Choice for Larger Reinforcer
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80
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40
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LEW
LEW 0-s probes
F344
F344 0-s probes

0
Block 1 Block 2 Block 3

Block 4
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Delay to Larger Reinforcer (s)

Figure 1. Mean percent larger-reinforcer choice as a function of delay blocks for the last five
baseline sessions (circles) and for 0-sec probe sessions (squares) conducted during the terminal
(baseline) delay series for LEW (closed symbols) and F344 (open symbols) rats. Error bars
represent standard error of the mean. The x-axis is composed of blocks rather than delay values
as two LEW and three F344 rats responded in a 0, 5, 10, 20, and 40-s delay series, and six LEW
and five F344 rats responded in a 0, 2, 4, 8, and 16-s delay series. During 0-s probe sessions the
delay to the larger reinforcer was 0 s across all five blocks of trials.
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Figure 2. Mean indifference points (left panel) and AUC (right panel) from the last five sessions
of the terminal (baseline) delay series for LEW (filled bars) and F344 (open bars) rats. Error
bars represent standard error of the mean. Single and double asterisks represent strain
differences at p < .05 and p < .01, respectively
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Determination of the Acute Dose-Response Function
One F344 rat died before acute drug administration; acute analyses are therefore based on
eight LEW and seven F344 rats. Table 1 shows the number of sessions conducted during the
acute phase and number of 0-s probe sessions conducted during this condition for individual
subjects. There were no differences between the number of sessions for LEW and F344 rats to
complete the acute drug administration phase or the number of 0-s probe sessions conducted
during this phase.
Figure 3 shows mean percent larger-reinforcer choice for vehicle and each dose of acute
diazepam as a function of delay to the larger reinforcer (displayed as blocks of trials) for LEW
(left panel) and F344 (right panel) rats during acute drug administration. For LEW rats, mean
percent larger-reinforcer choice did not change relative to vehicle for any dose of diazepam
administered, though it appears to trend toward an increase in larger-reinforcer choice following
administration of the largest dose of diazepam tested (10.0 mg/kg). This trend is largely a result
of choice for two subjects and is discussed further when results for indifference points and AUC
are reported. For F344 rats, mean percent larger-reinforcer choice decreased (i.e., more
impulsive choices) following acute administration of the largest dose of diazepam tested
compared to vehicle administration.
The above findings are also indicated in Figure 4, which shows indifference points (top
panel) and AUC (bottom panel) for LEW (closed symbols) and F344 (open symbols) rats as a
function of acute doses of diazepam (see Tables 2 and 3 for individual-subject data). It is
important to note that baseline strain differences in impulsive choice persisted throughout the
acute drug phase as indifference points were shorter and AUC were smaller for LEW compared
to F344 rats during control sessions (non-drug sessions) [F(1,14) = 7.88, p < .05; F(1,14) = 6.75,
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p < .05, respectively]. LEW rats also had shorter indifference points following vehicle
administration relative to F344 rats [F(1,14) = 4.68, p = .05]. Acute administration of diazepam
had differential effects for each rat strain. For LEW rats, there was no significant effect of dose
on indifference points or AUC. Following administration of the 10.0 mg/kg dose of diazepam,
there was an increase in mean indifference points relative to vehicle administration, however,
effects at this dose were not systematic across subjects. The mean was largely affected by two
outliers; large increases in indifference points and AUC were observed for LEW-2 and LEW-3 at
this dose relative to vehicle administration (see Tables 2 and 3).
For LEW rats, further examination of individual-subject data (see Tables 2 and 3),
revealed that diazepam did affect larger-reinforcer choice, however, the effect occurred at
different doses. For all subjects (8 of 8), at least one of the three doses administered increased
AUC relative to vehicle. Statistical analysis comparing acute vehicle administration to the
largest AUC obtained for each subject across the three doses administered revealed a significant
increase in AUC [F(1,7) = 6.91, p < .05]. The analysis included AUC at the 1.0 mg/kg dose for
LEW-6 and LEW-7, at the 3.0 mg/kg dose for LEW-1, LEW-5, and LEW-8, and at the 10.0
mg/kg dose for LEW-2, LEW-3, and LEW-4 relative to vehicle administration (see Table 3).
For F344 rats, diazepam had dose-dependent effects on indifference points and AUC
[F(4,24) = 5.89, p < .01; F(4,24) = 12.25, p < .01, respectively]. Although not statistically
significant, compared to vehicle administration, there was at least a slight increase in
indifference points and AUC in six of seven and five of seven F344 rats following acute
administration of 1.0 and 3.0 mg/kg of diazepam, respectively (see Tables 2 and 3). Indifference
points and AUC did not increase following at least one of these doses for only one subject
(F344-6). When this subject was not included in the analyses, AUC following 1.0 mg/kg were
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significantly greater than AUC following vehicle administration [F(1,5) = 7.66, p < .05], and
indifference points following 3.0 mg/kg were significantly longer than indifference points
following vehicle administration [F(1,5) = 6.84, p < .05]. For F344 rats, there was a significant
decrease in indifference points and AUC following administration of the largest dose of
diazepam (10.0 mg/kg) relative to vehicle administration [F(1,6) = 9.45, p < .05; F(1,6) = 15.81,
p < .01, respectively]. The observed decrease in larger-reinforcer choice at the 10.0 mg/kg dose
of diazepam relative to vehicle occurred for six of the seven F344 rats (see Tables 2 and 3).
Comparisons between rat strains at each dose revealed that indifference points were
shorter and AUC were smaller for LEW rats compared to F344 rats following administration of
the 1.0 mg/kg dose of diazepam [F(1,14) = 6.71, p < .05; F(1,14) = 10.31, p < .01, respectively].
The opposite occurred at the largest dose of diazepam (i.e., greater impulsive choice for F344
rats). AUC at this dose decreased to a smaller value for F344 relative to LEW rats [F(1,14) =
8.54, p < .05].
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Table 2
Subject, terminal delay series (Delay Series), and indifference points for each subject during the terminal delay series (Baseline),
determination of the acute dose-response function (Control, VEH, 1.0, 3.0, and 10.0 mg/kg), first five (First 5 Repeated) and last
five (Last 5 Repeated) sessions of repeated administration of diazepam for 30-50 sessions, determination of the chronic doseresponse function (VEH, 1.0, 3.0, and 10.0 mg/kg), and baseline replication at the end of experimentation (Baseline 2).
Acute Dose (mg/kg)
Subject

Delay
Series

Baseline

Control

VEH

1.0

3.0

10.0

LEW-1
LEW-2
LEW-3
LEW-4
LEW-5
LEW-6
LEW-7
LEW-8

16
40
16
16
16
16
40
16

7.67
10.25
8.09
4.27
3.52
7.38
6.33
4.91

9.78
10.17
6.84
5.05
4.01
5.33
8.89
6.07

7.89
10.92
5.89
5.30
4.92
6.18
9.35
3.73

9.04
9.73
8.34
5.25
4.90
6.70
8.68
4.75

10.78
12.85
14.52
5.25
5.40
3.11
7.97
7.41

9.57
63.20
20.66
6.76
3.19
2.65
9.46
5.00

6.55 (0.8)

7.02 (0.8)

6.77 (0.9)

7.17 (0.7)

8.41 (1.4)

15.06 (7.2)

8.88
9.67
42.88
16.96
8.26
15.32
27.95
8.38

7.34
9.70
12.98
14.23
7.45
14.91
21.91
--/--

4.96
5.79
15.00
12.60
6.51
21.28
21.04
--/--

7.59
14.64
17.05
13.03
8.61
14.37
35.20
--/--

5.26
12.09
18.61
17.36
5.56
3.80
28.90
--/--

5.26
2.25
5.35
5.08
3.00
3.00
1.53
--/--

17.29 (4.4)

12.65 (1.9)

12.45 (2.6)

15.78 (3.5)

13.08 (3.5)

3.64 (0.6)

M(SEM)
F344-1
F344-2
F344-3
F344-4
F344-5
F344-6
F344-7
F344-8

16
16
40
40
16
16
40
16

M(SEM)

Chronic Dose (mg/kg)
Subject

Delay
Series

First 5
Repeated

Last 5
Repeated

VEH

1.0

3.0

10.0

Baseline 2

LEW-1
LEW-2
LEW-3
LEW-4
LEW-5
LEW-6
LEW-7
LEW-8

16
40
16
16
16
16
40
16

18.32
45.89
9.98
3.89
3.46
2.79
--/-5.22

11.95
92.16
2.48
7.26
5.02
3.72
--/-6.04

7.79
16.02
1.50
4.22
3.22
5.78
--/-4.50

13.39
8.76
3.30
3.85
3.89
3.29
--/-5.60

14.86
10.00
2.89
4.00
5.69
5.84
--/-6.51

17.45
17.22
3.96
5.43
3.13
4.89
--/-4.93

7.22
7.59
5.60
6.02
5.12
5.31
--/-4.96

6.15 (1.8)

6.01 (1.4)

7.11 (1.5)

8.14 (2.4)

5.97 (0.4)

12.79 (5.9) 18.38 (12.4)

M(SEM)
F344-1
F344-2
F344-3
F344-4
F344-5
F344-6
F344-7
F344-8
M(SEM)

16
16
40
40
16
16
40
16

5.58
9.89
3.06
0.29
2.00
--/-5.37
--/--

3.92
5.44
3.70
2.27
6.43
--/-4.00
--/--

5.05
3.24
4.87
6.80
3.72
--/-4.82
--/--

5.11
4.54
4.62
5.35
3.52
--/-6.12
--/--

5.61
5.28
4.62
2.99
4.63
--/-3.43
--/--

1.30
2.62
3.88
1.39
5.14
--/-3.43
--/--

10.34
4.14
4.44
7.13
4.07
--/-5.43
--/--

4.37 (1.8)

4.29 (0.6)

4.75 (0.5)

4.88 (0.4)

4.43 (0.4)

2.96 (0.6)

5.93 (1.0)
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Table 3
Subject, terminal delay series (Delay Series), and AUC for each subject during the terminal delay series (Baseline),
determination of the acute dose-response function (Control, VEH, 1.0, 3.0, and 10.0 mg/kg), first five (First 5 Repeated) and
last five (Last 5 Repeated) sessions of repeated administration of diazepam for 30-50 sessions, determination of the chronic
dose-response function (VEH, 1.0, 3.0, and 10.0 mg/kg), and baseline replication at the end of experimentation (Baseline 2).
Acute Dose (mg/kg)
Subject

Delay
Series

Baseline

Control

VEH

1.0

3.0

10.0

LEW-1
LEW-2
LEW-3
LEW-4
LEW-5
LEW-6
LEW-7
LEW-8

16
40
16
16
16
16
40
16

0.5188
0.3604
0.5475
0.3688
0.2708
0.4875
0.2792
0.4000

0.5755
0.3581
0.4848
0.3611
0.3414
0.3938
0.3326
0.4368

0.5188
0.3924
0.4115
0.3984
0.3527
0.4405
0.3423
0.3188

0.5417
0.3507
0.5156
0.3802
0.3464
0.4427
0.3438
0.3472

0.6181
0.3993
0.6641
0.3594
0.3792
0.2344
0.3385
0.5078

0.5833
0.6528
0.8151
0.4766
0.2526
0.1979
0.3151
0.3854

0.4041 (0.04)

0.4105 (0.03)

0.3969 (0.02)

0.4085 (0.03)

0.4376 (0.05)

0.4599 (0.08)

0.5458
0.6021
0.7896
0.4875
0.5583
0.7417
0.6250
0.5625

0.5331
0.6078
0.4152
0.4262
0.5558
0.7786
0.5317
--/--

0.3872
0.4219
0.4340
0.3958
0.4524
0.8167
0.5295
--/--

0.5443
0.7361
0.4618
0.4167
0.5391
0.6328
0.6563
--/--

0.3724
0.6354
0.4896
0.4618
0.4167
0.3464
0.5885
--/--

0.4005
0.1510
0.1424
0.1875
0.2057
0.1979
0.1615
--/--

0.6141 (0.04)

0.5498 (0.05)

0.4911 (0.06)

0.5696 (0.04)

0.4730 (0.04)

0.2066 (0.03)

M(SEM)
F344-1
F344-2
F344-3
F344-4
F344-5
F344-6
F344-7
F344-8

16
16
40
40
16
16
40
16

M(SEM)

Chronic Dose (mg/kg)
Subject

Delay
Series

First 5
Repeated

Last 5
Repeated

VEH

1.0

3.0

10.0

Baseline 2

LEW-1
LEW-2
LEW-3
LEW-4
LEW-5
LEW-6
LEW-7
LEW-8

16
40
16
16
16
16
40
16

0.7792
0.6292
0.5771
0.2750
0.2271
0.2021
--/-0.4104

0.6375
0.6583
0.2167
0.5104
0.3604
0.2646
--/-0.4250

0.5025
0.4323
0.0938
0.3646
0.3188
0.4229
--/-0.3576

0.6632
0.3368
0.2188
0.2865
0.3021
0.2370
--/-0.3958

0.7917
0.3854
0.2500
0.3438
0.3924
0.4167
--/-0.4640

0.7813
0.4509
0.3423
0.3929
0.2642
0.3542
--/-0.4089

0.5125
0.3167
0.3833
0.4000
0.3750
0.3708
--/-0.3479

0.3561 (0.05)

0.3486 (0.06)

0.4349 (0.06)

0.3576
0.2750
0.1181
0.1823
0.2726
--/-0.1389
--/--

0.3698
0.3672
0.1042
0.1424
0.2500
--/-0.2083
--/--

0.4028
0.4236
0.1042
0.1146
0.3490
--/-0.0885
--/--

0.1797
0.2240
0.0848
0.0532
0.3798
--/-0.0885
--/--

0.6479
0.2938
0.1063
0.2104
0.3250
--/-0.1833
--/--

0.2241 (0.04)

0.2403 (0.05)

0.2471 (0.07)

0.1683 (0.05)

0.2945 (0.08)

0.4429 (0.08) 0.4390 (0.07)

M(SEM)
F344-1
F344-2
F344-3
F344-4
F344-5
F344-6
F344-7
F344-8
M(SEM)

16
16
40
40
16
16
40
16

0.3958
0.5979
0.0896
0.0604
0.1958
--/-0.2583
--/--

0.3271
0.4000
0.0875
0.0708
0.4500
--/-0.0979
--/--

0.2663 (0.08) 0.2389 (0.07)

0.4278 (0.06) 0.3866 (0.02)
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Figure 3. Mean percent larger-reinforcer choice as a function of delay for acute diazepam
administration, including vehicle (closed squares), 1.0 (open circles), 3.0 (open triangles), and
10.0 (gray diamonds) mg/kg of diazepam for LEW (left panel) and F344 (right panel) rats. Error
bars represent standard error of the mean. The x-axis is composed of blocks rather than delay
values as two LEW and three F344 rats responded in a 0, 5, 10, 20, and 40-s delay series, and six
LEW and four F344 rats responded in a 0, 2, 4, 8, and 16-s delay series.
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Figure 4. Mean indifference points (top panel) and AUC (bottom panel) as a function of doses of diazepam
(control, vehicle, 1.0, 3.0, and 10.0 mg/kg) during acute drug administration for LEW (closed symbols) and
F344 (open symbols) rats. Error bars represent standard error of the mean. Single and double asterisks
represent significance levels of p < .05 and p < .01, respectively, where differences occurred between rat strains
at a particular dose. Single and double crosses represent significance levels of p < .05 and p < .01, respectively,
where significant changes for a particular dose occurred relative to vehicle for each strain separately.
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Repeated (Chronic) Drug Administration
One LEW and one F344 rat did not receive repeated drug administration because the
terminal delay series required a much longer period of time to determine compared to other
subjects. Considering the lifespan of these rat strains, completing the repeated diazepam phase
would likely not have been possible or healthy for these subjects. Analyses throughout the rest
of the experiment are thus based on seven LEW and six F344 rats. Table 1 shows the chronic
dose of diazepam administered and the number of sessions conducted during the repeated drug
phase for individual subjects. There was no difference between the number of sessions required
for LEW and F344 rats to complete the repeated drug phase.
Figure 5 shows mean percent larger-reinforcer choice for acute vehicle administration
and the first and last five sessions of repeated diazepam administration (30-50 sessions) as a
function of delay to the larger reinforcer (displayed as blocks of trials) for LEW (left panel) and
F344 (right panel) rats (see Tables 2 and 3 for individual-subject data). Data from acute vehicle
administration were included here to compare repeated drug effects to a non-drug condition.
There was a differential effect of repeated diazepam administration between rat strains. For
LEW rats, mean larger-reinforcer choice during repeated diazepam administration was similar to
levels obtained during acute vehicle administration. For individual LEW rats however,
indifference points and AUC often did change during the first five sessions of repeated
administration, however, the effects were not systematic. For F344 rats, larger-reinforcer choice
during repeated diazepam administration decreased relative to acute vehicle administration.
Within the first five sessions of repeated diazepam administration, there was an overall decrease
in larger-reinforcer choice for four of six F344 rats. For individual subjects, the observed
decrease in larger-reinforcer choice only occurred for F344 rats that received the largest doses
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(5.6 and 10.0 mg/kg) of diazepam, and a slight increase across the first five sessions of repeated
diazepam occurred for the other F344 rats that received the smallest dose (1.0 mg/kg) of
diazepam repeatedly.
For both rat strains, there was little change in percent larger-reinforcer choice from the
first five to the last five sessions of repeated diazepam administration. For individual subjects,
indifference points and AUC often did change from the first to the last five sessions of this
phase, however, the effects were not systematic. When combined, any effects that occurred for
individual subjects were not apparent in the averages. Overall, across repeated diazepam
administration, mean percent larger-reinforcer choice remained unchanged for LEW rats and for
F344 rats, decreased within the first five sessions and remained low across the repeated phase.
The mean AUC during the last five sessions of repeated diazepam administration for F344 rats
was nearly significantly smaller relative to acute vehicle administration [F(1,5) = 6.49, p = .051].
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Figure 5. Mean percent larger-reinforcer choice as a function of delay during acute vehicle
administration (closed squares) and the first (open triangles) and last (gray triangles) five
sessions of repeated diazepam administration. Error bars represent standard error of the mean.
The x-axis is composed of blocks as one LEW and three F344 rats responded in a 0, 5, 10, 20,
and 40-s delay series, and six LEW and three F344 rats responded in a 0, 2, 4, 8, and 16-s delay
series.
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Determination of the Chronic Dose-Response Function
Table 1 shows the number of sessions conducted during determination of chronic doseresponse functions for individual subjects. There was no difference between the number of
sessions required for LEW and F344 rats to complete this phase. Figure 6 shows mean percent
larger-reinforcer choice for vehicle and each dose of repeated diazepam as a function of delay to
the larger reinforcer (displayed as blocks of trials) for LEW (left panel) and F344 (right panel)
rats during determination of the chronice dose-response function. For both rat strains, mean
percent larger-reinforcer choice did not change systematically for any chronic dose of diazepam
administered.
The above findings are also indicated in Figure 7, which shows indifference points (top
panels) and AUC (bottom panels) for LEW (left panels) and F344 (right panels) rats as a
function of acute and chronic doses of diazepam (see Tables 2 and 3 for individual-subject data).
Again, for LEW rats, there was no effect of dose on indifference points or AUC during
determination of the chronic dose-response function, and indifference points and AUC during
chronic diazepam administration were not different from those obtained during acute diazepam
administration. The large increases that had occurred for LEW-2 and LEW-3 during acute
administration of the 10.0 mg/kg dose of diazepam no longer occurred when it was administered
during the chronic dose-response determinations.
For F344 rats, there was an overall decrease in larger-reinforcer choice from the acute to
repeated diazepam phases as indicated by an overall decrease in indifference points and AUC
across all doses of diazepam administered (see Figure 7). When vehicle was administered (nondrug sessions), AUC for F344 rats decreased relative to acute vehicle administration [F(1,5) =
16.71, p < .01]. Indifference points and AUC for F344 rats also decreased significantly from
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acute to chronic administration of 1.0 [F(1,5) = 8.31, p < .05; F(1,5) = 68.65, p < .01,
respectively] and 3.0 mg/kg [F(1,5) = 6.59, p = .05; F(1,5) = 8.99, p < .05, respectively] of
diazepam. Indifference points and AUC at the largest dose administered (10.0 mg/kg) remained
low across the acute and chronic diazepam conditions. Considering these results in combination
with the decreases in larger-reinforcer choice within the first five sessions of repeated diazepam
administration, a baseline shift occurred for F344 rats that remained throughout all repeated
phases of diazepam administration.
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Figure 6. Mean percent larger-reinforcer choice as a function of delay during determination of
the chronic dose-response function, including vehicle (closed squares), 1.0 (open circles), 3.0
(open triangles), and 10.0 (gray diamonds) mg/kg of diazepam for LEW (left panel) and F344
(right panel) rats. Error bars represent standard error of the mean. The x-axis is composed of
blocks rather than delay values as one LEW and three F344 rats responded in a 0, 5, 10, 20, and
40-s delay series, and six LEW and three F344 rats responded in a 0, 2, 4, 8, and 16-s delay
series.
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Figure 7. Mean indifference points (top panels) and AUC (bottom panels) as a function of doses
of diazepam (vehicle, 1.0, 3.0, and 10.0 mg/kg) during acute (closed symbols) and chronic (open
symbols) drug administration for LEW (left panels) and F344 (right panels) rats. Error bars
represent standard error of the mean. Single and double asterisks represent significance levels of
p < .05 and p < .01, respectively, where differences occurred between acute and chronic
administration at a particular dose.
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Baseline Replication
Table 1 shows the number of sessions required to meet criterion (80% larger-reinforcer
choice across all blocks of trials) during 0-s probe sessions after completion of chronic drug
administration and number of sessions conducted during the baseline replication condition for
individual subjects as well as means and standard error of the mean for each strain separately.
There was no difference between the number of sessions for LEW and F344 rats to meet the
criterion during 0-s probe sessions or to reach stability during baseline replication.
Figure 8 shows mean percent larger-reinforcer choice as a function of delay to the larger
reinforcer (displayed as blocks of trials) for only those LEW (left panel) and F344 (right panel)
rats that completed the chronic drug phase. Choice data are from the last five sessions of the
terminal baseline phase conducted at the beginning of experimentation (prior to drug
administration) and the last five sessions of the baseline replication condition during which drug
administration had ceased. During the initial baseline phase, LEW rats chose the largerreinforcer less than F344 rats. This was indicated by shorter indifference points and smaller
AUC for LEW rats. Upon the baseline replication, the differences in larger-reinforcer choice
were no longer present (see Tables 2 and 3 for individual-subject data). Similar rates of
discounting occurred for LEW and F344 rats, and this was indicated by similar indifference
points and AUC during the baseline replication phase for each strain. Throughout
experimentation, indifference points and AUC remained relatively unchanged for LEW rats,
while indifference points were initially longer and AUC were initially larger for F344 rats. Early
in the repeated administration phase, indifference points and AUC for F344 rats decreased and
remained at low levels throughout experimentation.
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Figure 8. Mean percent larger-reinforcer choice as a function of delay blocks for the last five
sessions conducted during the terminal (baseline) delay series (circles) and last five sessions
from the baseline replication phase (squares) for only those LEW (left panel) and F344 (right
panel) rats that completed all phases of the experiment. Error bars represent standard error of the
mean. The x-axis is composed of blocks rather than delay values as one LEW and three F344 rats
responded in a 0, 5, 10, 20, and 40-s delay series, and six LEW and three F344 rats responded in
a 0, 2, 4, 8, and 16-s delay series.
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Discussion
Consistent with previous research (e.g., Anderson & Woolverton, 2005; Madden et al.,
2008), delay discounting was observed for both rat strains in that, as delay to the larger reinforcer
increased, choice for that alternative decreased. Delay series for individual subjects were
functionally determined and, despite obtaining steeper discounting functions and smaller AUC
for LEW rats, intermediate functions were obtained for both rat strains. LEW rats had shorter
indifference points compared to F344 rats, and this finding is consistent with previous research
using the same discounting procedure where delays systematically increased within sessions
(Anderson & Woolverton; Anderson & Diller, 2010; Garcia-Lecumberri et al., 2010; Huskinson
et al., revisions submitted) and using a different procedure where delays systematically increased
between sessions (Madden et al., 2008). Despite significant differences in mean indifference
points at baseline, there was some overlap between strains. For example, relatively long
indifference points were observed for two LEW rats that were similar to the four shortest
indifference points observed for F344 rats.
In the current study, LEW rats required more 0-s probe sessions during the terminal
(baseline) delay series compared to F344 rats. It is possible that LEW rats were less sensitive to
differences in reinforcer amount, and this could have contributed to differences in baseline rates
of delay discounting. However, differences in the number sessions required to pass 0-s probe
sessions were no longer present during the acute phase, yet rates of discounting were steeper for
LEW compared to F344 rats during non-drug sessions (vehicle and control sessions). It is also
possible that sensitivity to reinforcer delay is different for LEW compared to F344 rats. The
procedure used, however, cannot separate effects of reinforcer amount and delay, and strain
differences in discounting may result from differential control by reinforcer amount, delay, or
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both. Neurochemical differences also could have contributed to differences in baseline rates of
delay discounting between these rat strains. In general, LEW rats have lower levels of DA and
5-HT in various brain regions relative to F344 rats (Burnet et al., 1992; Flores et al., 1998; Selim
& Bradberry, 1996), and depletion of these neurotransmitters is related to steeper rates of
discounting (Kheramin et al., 2004; Mobini et al., 2000; Wogar et al., 1993). It is important to
note that neurochemical measures were not used in the present experiment, however, future
research correlating delay-discounting rates and neurotransmitter levels could provide empirical
support for this relation.
During the acute drug phase, steeper rates of discounting continued to occur for LEW
relative to F344 rats during control and vehicle sessions, thus, the baseline differences persisted
throughout the acute diazepam phase. For F344 rats, mean indifference points and AUC did
decrease slightly during control and vehicle sessions relative to those obtained at baseline, and
this effect did not occur for LEW rats. It is possible that larger-reinforcer choice gradually
declines with extended exposure to the task, particularly for subjects with initially shallower
discounting functions. In the current study, the two F344 rats with the longest indifference
points and largest AUC (F344-3 and F344-7) showed the greatest decrease from baseline to
control sessions. If extended exposure to the discounting task was responsible for the observed
decreases in larger-reinforcer choice for F344 rats, it would be likely that this effect would also
occur for LEW rats.
The finding that acute diazepam did not alter larger-reinforcer choice in LEW rats is
consistent with other research examining effects of acute diazepam administration on different
behavioral measures in LEW rats. Takahashi and colleagues (2001) examined effects of
different doses of diazepam on an elevated plus-maze task in LEW rats relative to spontaneously
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hypertensive rats (SHR). Doses that affected behavior in SHRs had no effect on behavior in
LEW rats. LEW rats were also less sensitive to behavioral effects of chlordiazepoxide, a
benzodiazepine, on a successive negative-contrast procedure compared to F344 rats (Freet,
Tesche, Tompers, Riegel, & Grigson, 2006). Within the same procedure, chlordiazepoxide
increased overall consumption of a sucrose solution for F344, but not LEW rats (Freet et al.,
2006).
Perhaps delay discounting is another measure that, in LEW rats, is not sensitive to effects
of benzodiazepines. Examination of individual-subject data suggested otherwise. Acute
diazepam did not affect mean larger-reinforcer choice in LEW rats when effects of each dose
were compared separately, but different doses of diazepam did have effects for individual
subjects. For example, at least one of the doses administered increased AUC in LEW rats
relative to vehicle, but which dose had this effect was variable across subjects and was obscured
by presenting only the means for each dose. Increased larger-reinforcer choice in LEW rats is
consistent with Evenden and Ryan’s (1996) findings that diazepam increased larger-reinforcer
choice in Sprague-Dawley rats. In studies that report no effect (Freet et al., 2006; Takahashi et
al., 2001), it is possible that individual LEW rats were insensitive to benzodiazepine
administration or that effects were observed for individual LEW rats that were obscured by
reporting only the group means. This highlights the importance of reporting individual-subject
data, particularly in experiments that use small-n designs.
For F344 rats, at least one of the two smallest doses (1.0 and 3.0 mg/kg) of diazepam
increased indifference points and AUC for all but one F344 rat, and this is also consistent with
Evenden and Ryan’s (1996) results with diazepam in Sprague-Dawley rats. Conversely, the
largest dose of diazepam decreased larger-reinforcer choice in F344 rats, and this is consistent
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with Cardinal et al.’s (2000) finding that relatively large doses of chlordiazepoxide decrease
larger-reinforcer choice in Listar hooded rats. Evenden and Ryan and Cardinal et al. are used
here as a comparison, because both studies used a delay-discounting procedure that was similar
to the one used in the present study. A majority of the research examining effects of
benzodiazepines on delay discounting have used a T-maze procedure. Comparisons between the
current study and those using a T-maze procedure are more difficult because there are many
differences in procedural variables.
Within the type of procedure used in the current study and also by Evenden and Ryan
(1996) and Cardinal et al. (2000), it is possible that discrepant findings with benzodiazepines and
delay discounting result from differential sensitivities to different doses of diazepam in different
rat strains and different subjects within a given rat strain. It seems that an increase in largerreinforcer choice, despite occurring at different doses for different subjects is a systematic effect
worth noting. When experimenters do not report individual-subject data, at least for small-n
designs, it is not clear whether an effect did not occur, or whether an effect did occur but was
observed at different doses for different subjects and was obscured by reporting group means
only. Neither Evenden and Ryan nor Cardinal et al. report individual-subject data.
It is also possible that discrepant findings with benzodiazepines and delay discounting
result from administration of an insufficient range of doses. For example, Evenden and Ryan
(1996) found increases in larger-reinforcer choice following smaller doses of diazepam (0.3 and
1.0 mg/kg). Other doses of diazepam were not tested. Cardinal et al. (2000) found decreases in
larger-reinforcer choice following administration of the largest dose of chlordiazepoxide tested
(10.0 mg/kg). These researchers used multiple doses, but did not examine effects of doses
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smaller than 1.0 mg/kg. The present experiment found increases and decreases in largerreinforcer choice depending on strain and dose of diazepam.
The increases in larger-reinforcer choice observed for individual LEW and F344 rats
following acute diazepam administration may have resulted from benzodiazepine’s ability to
enhance consumption and palatability of food (see Cooper, 2004 for a review). If diazepam
functioned to enhance palatability of food, it may have also increased control of choice by
reinforcer amount. It cannot be ruled out, however, that diazepam altered control of choice by
reinforcer delay or both amount and delay. Again, based on the procedures used in the current
study, it is not possible to separate drug effects on choice controlled by differences in reinforcer
amount and reinforcer delay (Pitts & Febbo, 2004).
The decreases in larger-reinforcer choice observed for F344 rats following acute
diazepam administration may be related to effects of benzodiazepine administration on DA and
5-HT. For example, benzodiazepines decreased extracellular levels of DA and 5-HT neuronal
activity in specific brain regions (Finlay et al., 1995; Stein et al., 1975). Administration of the
largest dose may have resulted in lower levels of DA and 5-HT that contributed to steeper rates
of discounting in F344 rats. Larger-reinforcer choice did not decrease for LEW rats following
acute administration of diazepam. LEW rats already have lower levels of DA and 5-HT, and it is
possible that a floor effect occurred with these rats. Again, neurochemical measures were not
taken in the current study, and future research could correlate DA and 5-HT levels with rates of
discounting following benzodiazepine administration.
During the repeated diazepam phase, there were no systematic effects for LEW rats when
larger-reinforcer choice was compared during a non-drug condition (acute vehicle) to the first
five sessions of repeated administration. The dose administered during the repeated phase
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(chronic dose) was functionally determined for the greatest change in choice, and overall, was
different for individual subjects. For two LEW rats, this dose initially decreased largerreinforcer choice when administered during the acute phase, and for five LEW rats, this dose
initially increased larger-reinforcer choice during the acute phase. If only those doses that
increased larger-reinforcer choice (or vice versa) were chosen as the repeated dose for all
subjects, more systematic effects may have occurred. Because it was unclear during the acute
phase whether diazepam would increase, decrease, or have no effect on larger-reinforcer choice,
it was not possible to set this type of criterion in advance. This could also have resulted in
failure to find systematic changes in larger-reinforcer choice for LEW rats from the first five to
the last five sessions of the repeated phase.
For F344 rats, larger-reinforcer choice did decrease during the first five sessions of the
repeated phase in the four F344 rats that received the largest doses of diazepam as their repeated
dose. With these subjects, larger-reinforcer choice decreased rapidly and remained low across the
repeated phase. By the end of the repeated phase, larger-reinforcer choice had decreased relative
to acute vehicle for all six F344 rats. That more systematic effects occurred for F344 relative to
LEW rats is consistent with other studies examining repeated exposure to diazepam in LEW and
F344 rats. For example, LEW rats show fewer signs of physical dependence and withdrawal
compared to F344 rats following repeated exposure and removal of food mixed with diazepam
(Suzuki et al., 1992). This difference in physical dependence occurred despite having similar
blood-diazepam levels across both strains.
Compared to acute administration of diazepam, chronic diazepam administration had no
effect on mean percent larger-reinforcer choice for LEW rats. Indifference points and AUC
across all doses were similar to those obtained during both acute and chronic vehicle
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administration. However, the variability in indifference points and AUC across subjects
decreased for LEW rats following chronic diazepam administration. For F344 rats, the overall
decrease in larger-reinforcer choice that occurred during the first five days of repeated diazepam
administration persisted during determination of the chronic dose-response functions. Across all
doses administered, including vehicle, indifference points and AUC were similar to those
obtained following acute administration of the largest dose of diazepam. Following many weeks
(and months by the end of this phase) of daily diazepam dosing, levels of DA and 5-HT may
have decreased to levels that could not recover when vehicle or smaller doses of diazepam were
administered.
During the baseline replication phase, when all injections ceased, the rate of discounting
for LEW rats was similar to the rate of discounting observed for these rates during the initial
baseline condition. Thus, delay discounting in LEW rats remained, at least on average, relatively
unchanged across multiple conditions of the experiment. For F344 rats, the overall decrease in
larger-reinforcer choice observed early in repeated diazepam exposure, persisted into the
baseline replication phase. It seems that the baseline shift in F344 rats could have occurred for at
least three reasons. First, repeated diazepam could have resulted in a relatively permanent
baseline shift in larger-reinforcer choice. Rats that completed repeated conditions of diazepam
administration were exposed to daily diazepam administration for two to three months. If the
initial baseline shift that occurred within the first five sessions of repeated administration was not
relatively permanent, one might expect larger-reinforcer choice to return to baseline levels as
individual subjects became tolerant to diazepam’s effects. This did not occur throughout
repeated administration nor did rates of discounting return to initial baseline levels following a
minimum of 20 sessions on the delay-discounting task when drug was no longer administered.
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The second and third potential reasons for an overall decrease in larger-reinforcer choice
for F344 rats could have been repeated exposure to the delay-discounting task and subject
maturation, respectively. Exposure to diazepam across the multiple conditions of the
experiment, exposure to the discounting task, and subject maturation were confounded
throughout experimentation. It is possible that as F344 rats aged or experienced continued
exposure to the task, larger-reinforcer choice would have decreased anyway. However, the
finding that aged F344 rats have shallower discounting functions compared to young F344 rats,
using a similar procedure to the one used in the current study, would predict the opposite (Simon
et al., 2010). The findings from Simon and colleagues do not help to rule out extended exposure
to the discounting task as a potential contributor to decreases in larger-reinforcer choice as both
aged and young F344 rats were exposed to the task for a short period of time. That the same
overall decrease in larger-reinforcer choice did not occur for LEW rats, however, makes effects
of both age and exposure to the task less plausible.
The present study is the first to report acute and repeated effects of diazepam on delay
discounting in LEW and F344 rats. LEW and F344 rats have behavioral and neurochemical
differences that are correlated with baseline rates of delay discounting. Acute administration of
diazepam had differential effects on larger-reinforcer choice in LEW and F344 rats and for
individual subjects within each strain. Repeated administration of diazepam did not
systematically affect larger-reinforcer choice in LEW rats and resulted in an overall decrease in
larger-reinforcer choice for F344 rats that persisted throughout a baseline replication phase. It
seems that the results discussed above have raised more questions about, and potential directions
for future investigation of, multiple environmental, genetic, and neurochemical variables
involved in delay discounting and effects of benzodiazepines on delay discounting.
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